tradingkey.logo
tradingkey.logo
Search

Quoin Pharmaceuticals Ltd

QNRX
Add to Watchlist
6.900USD
-0.070-1.00%
Close 09-10 16:00ET
486.44MMarket Cap
LossP/E TTM
After-hours  (ET)0.000USD0.000

QNRX Financials

See Quoin Pharmaceuticals Ltd's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Key Financial Ratios

Market Cap
486.44M
Dividend TTM
0.00
P/E TTM
-0.69
EPS TTM
-10.06
Revenue
--
Net Profit
-8.96M
ROE
-231.18%
ROA
-118.61%

Quoin Pharmaceuticals Ltd Earnings Date

Latest Release
Aug 14, 2026
EPS / Forecast
--/-1.61
Revenue / Forecast
--/0.00

Financial Statement Highlights

Quarterly
Quarterly+Annual
Quarterly
Annual
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
Financial Indicators
EPS
69.83%-66.36
72.85%-61.79
85.99%-60.64
58.79%-234.94
54.07%-219.93
83.21%-227.56
88.93%-432.83
-1551066.67%-570.05
-81341.67%-478.88
-230418.75%-1.36K
-332460.42%-3.91K
---0.04
---0.59
---0.59
---1.18
---0.13
----
----
----
----
Net Profit
-45.32%-5.37M
-31.10%-5.00M
-88.14%-4.35M
-68.02%-3.95M
-87.23%-3.70M
-63.80%-3.81M
-12.75%-2.31M
-21.97%-2.35M
6.31%-1.97M
10.59%-2.33M
-2.44%-2.05M
37.75%-1.93M
21.03%-2.11M
-54.69%-2.60M
83.07%-2.00M
-120.41%-3.09M
38.49%-2.67M
56.89%-1.68M
-673.74%-11.82M
-193.84%-1.40M
Debt to assets ratio
-42.57%16.91%
-35.30%13.85%
-38.77%11.40%
42.69%38.51%
28.34%29.44%
2.32%21.41%
-35.73%18.61%
10.69%26.99%
-2.94%22.94%
-4.05%20.92%
1.52%28.96%
--24.38%
--23.63%
--21.81%
--28.52%
--26.00%
----
----
----
----
Operating profit
-44.30%-5.47M
-29.67%-5.13M
-87.96%-4.52M
-59.02%-4.02M
-77.49%-3.79M
-60.97%-3.96M
-8.45%-2.41M
-18.95%-2.53M
5.44%-2.14M
11.43%-2.46M
-6.32%-2.22M
8.69%-2.13M
15.30%-2.26M
-27.55%-2.78M
30.04%-2.09M
-78.66%-2.33M
-173.13%-2.67M
-171.41%-2.18M
-157.32%-2.98M
-75.97%-1.30M
Net Profit
-45.32%-5.37M
-31.10%-5.00M
-88.14%-4.35M
-68.02%-3.95M
-87.23%-3.70M
-63.80%-3.81M
-12.75%-2.31M
-21.97%-2.35M
6.31%-1.97M
10.59%-2.33M
-2.44%-2.05M
37.75%-1.93M
21.03%-2.11M
-54.69%-2.60M
83.07%-2.00M
-120.41%-3.09M
38.49%-2.67M
56.89%-1.68M
-673.74%-11.82M
-193.84%-1.40M
Current assets
37.23%11.64M
22.71%15.33M
34.04%20.01M
-42.70%6.02M
-35.87%8.48M
-18.13%12.50M
32.25%14.93M
-25.77%10.50M
-15.65%13.22M
-12.21%15.26M
-15.59%11.29M
-9.68%14.14M
345.95%15.67M
189.88%17.39M
57.33%13.37M
1533.21%15.66M
73.80%3.51M
337.30%6.00M
58.19%8.50M
-84.81%958.71K
Total current liabilities
52.46%6.61M
10.10%5.35M
32.67%5.55M
65.95%5.76M
9.74%4.34M
14.95%4.86M
16.74%4.18M
-24.16%3.47M
-10.45%3.95M
1.48%4.22M
1.53%3.58M
27.34%4.58M
20.41%4.41M
16.05%4.16M
-22.91%3.53M
-73.50%3.60M
-72.04%3.67M
-65.25%3.59M
392.04%4.58M
1616.86%13.57M
Total assets
34.30%11.97M
21.13%15.69M
29.80%20.39M
-43.60%6.42M
-36.59%8.91M
-19.65%12.96M
29.09%15.71M
-24.41%11.39M
-15.89%14.05M
-12.61%16.12M
-15.83%12.17M
-8.34%15.07M
286.68%16.71M
170.09%18.45M
54.52%14.46M
791.77%16.44M
47.34%4.32M
202.49%6.83M
53.44%9.36M
-73.85%1.84M
Total liabilities
26.34%8.04M
-1.56%6.92M
11.78%7.27M
28.43%7.64M
-3.27%6.36M
0.45%7.03M
-0.01%6.50M
-22.30%5.95M
-13.90%6.58M
-7.15%7.00M
-7.74%6.51M
5.28%7.65M
1.98%7.64M
-0.32%7.54M
-18.95%7.05M
-59.82%7.27M
-57.88%7.49M
-40.79%7.56M
507.36%8.70M
1336.90%18.10M
Total equity
54.14%3.93M
48.05%8.77M
42.54%13.12M
-122.32%-1.21M
-65.88%2.55M
-35.06%5.93M
62.51%9.20M
-26.60%5.44M
-17.57%7.48M
-16.39%9.13M
-23.53%5.66M
-19.13%7.41M
386.35%9.07M
1596.34%10.91M
1027.31%7.41M
156.41%9.17M
78.66%-3.17M
93.06%-729.41K
-85.92%657.03K
-380.78%-16.25M
Net operating income
14.70%-3.14M
-87.69%-4.87M
-125.13%-5.04M
-2.12%-2.23M
-83.66%-3.69M
-80.86%-2.59M
30.62%-2.24M
-64.91%-2.18M
-27.62%-2.01M
17.87%-1.43M
-65.97%-3.22M
42.38%-1.32M
26.90%-1.57M
16.58%-1.75M
38.90%-1.94M
-152.71%-2.29M
-76.34%-2.15M
-406.03%-2.09M
-122.81%-3.18M
3.59%-907.54K
Net investment
138.77%4.02M
48.70%4.12M
-254.54%-11.27M
-2.42%2.54M
-46.67%1.68M
162.03%2.77M
-220.21%-3.18M
316685.75%2.60M
3.95%3.15M
-27.90%-4.47M
--2.64M
100.01%821.00
1617.50%3.04M
-6883.01%-3.49M
100.00%0.00
-9108.48%-9.90M
-60.00%-200.00K
64.91%-50.00K
-410.96%-250.00K
-138.55%-107.50K
Net financing
-1.30%-151.95K
143.85%55.98K
208.90%18.29M
-0.07%-150.00K
-10.07%-150.00K
-99.57%22.96K
3343.14%5.92M
45.49%-149.89K
-81.70%-136.28K
-7.25%5.33M
59.14%-182.58K
-101.86%-275.00K
50.00%-75.00K
3932.84%5.75M
-104.36%-446.86K
28060.15%14.75M
-107.55%-150.00K
-111.45%-150.00K
29310.83%10.26M
11.60%-52.77K

FAQs

What are the current assets of Quoin Pharmaceuticals Ltd?

According to Quoin Pharmaceuticals Ltd's FY2025 earnings report, its current assets were 20.01M, with a year-on-year change of 34.04.

What are the total assets of Quoin Pharmaceuticals Ltd?

According to Quoin Pharmaceuticals Ltd's FY2025 earnings report, its total assets of Quoin Pharmaceuticals Ltd were 20.39M, with a year-on-year change of 29.80.

What are the total liabilities of Quoin Pharmaceuticals Ltd?

According to Quoin Pharmaceuticals Ltd's FY2025 earnings report, its total liabilities of Quoin Pharmaceuticals Ltd were 7.27M, with a year-on-year change of 11.78.

What is the total equity of Quoin Pharmaceuticals Ltd?

According to Quoin Pharmaceuticals Ltd's FY2025 earnings report, its total equity of Quoin Pharmaceuticals Ltd was 13.12M, with a year-on-year change of 42.54.

What is the net operating income of Quoin Pharmaceuticals Ltd?

According to Quoin Pharmaceuticals Ltd's FY2025 earnings report, its net operating income of Quoin Pharmaceuticals Ltd was -16.29M, with a year-on-year change of -70.97.

What is the net investment of Quoin Pharmaceuticals Ltd?

According to Quoin Pharmaceuticals Ltd's FY2025 earnings report, its net investment of Quoin Pharmaceuticals Ltd was -4.28M, with a year-on-year change of -126.54.

What is the net financing of Quoin Pharmaceuticals Ltd?

According to Quoin Pharmaceuticals Ltd's FY2025 earnings report, its net financing of Quoin Pharmaceuticals Ltd was 18.01M, with a year-on-year change of 64.25.

What is the Earnings Per Share (EPS) of Quoin Pharmaceuticals Ltd?

According to Quoin Pharmaceuticals Ltd's FY2025 earnings report, its Earnings Per Share (EPS) was -517.87, with a year-on-year change of 77.88.

What is the net income of Quoin Pharmaceuticals Ltd?

According to Quoin Pharmaceuticals Ltd's FY2025 earnings report, its net income was -15.80M, with a year-on-year change of -76.34.

What is the debt-to-asset ratio of Quoin Pharmaceuticals Ltd?

According to Quoin Pharmaceuticals Ltd's FY2025 earnings report, its debt-to-asset ratio was 11.40, with a year-on-year change of -38.77.

What is the Return on Equity (ROE) of Quoin Pharmaceuticals Ltd?

According to Quoin Pharmaceuticals Ltd's FY2025 earnings report, its Return on Equity (ROE) was -141.59, with a year-on-year change of -17.45.

What is the Return on Assets (ROA) of Quoin Pharmaceuticals Ltd?

According to Quoin Pharmaceuticals Ltd's FY2025 earnings report, its Return on Assets (ROA) was -87.56, with a year-on-year change of -36.18.

What is the operating profit of Quoin Pharmaceuticals Ltd?

According to Quoin Pharmaceuticals Ltd's FY2025 earnings report, its operating profit was -16.29M, with a year-on-year change of -70.97.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.